For example, people with diabetes in New Zealand do have access to free and/or highly subsidised insulin, hypoglycaemic agents, glucose strips, etc., though this does require a visit to a general practitioner and a minimal prescription charge. This evidence concerns the gene INS and diabetes mellitus.